In a new study published in The Journal of Viral Hepatitis, researcher Hee-Soon Juon, MSN, PhD explores how stigma against HBV affects those with the condition.

In a new paper, published in EMBO Reports, a team including Davide Trotti, PhD, a neuroscientist at Thomas Jefferson University, showed how altered glucose metabolism in the brain and spinal cord are damaging to motor neurons in preclinical models that carry the genetic C9-NRE mutation. 

Molecular biologist Yohei Kirino, PhD and his research team at Thomas Jefferson University has found that certain RNA molecules in people with tuberculosis are drastically different than those in healthy people.

A recent study led by Preeti Zanwar, PhD, MPH, MS, an adjunct research and teaching faculty and aging and health disparities researcher at Jefferson, sheds light on the prevalence of multimorbidity among aging adults in India and recommends how public health officials can prevent adverse effects.

In a recent study, Scott A. Waldman, MD, PhD, and his team discovered that a gut receptor protein called GUCY2C could prevent PD development by protecting against brain damage and toxic insult.

“Recessive Dystrophic Epidermolysis Bullosa (RDEB) is the worst disease you’ve probably never heard of,” says dermatology researcher, Andrew South, PhD. RDEB patients and their families know just how horrible it can be.

In a new study in the American Journal of Preventive Medicine examining how patterns of prenatal substance use impact attention-deficit/hyperactivity disorder (ADHD) diagnoses in children, researchers found that co-use of alcohol and tobacco, and use of cannabis alone, posed the greatest risk.